Evidence map›Paper›PMID 41415274›Full record

ArticleFrontiers in immunology2025

Multiplexed longitudinal analysis of the cellular and microbial dynamics of acute polymicrobial sepsis in mice.

Tori E Peacock, Kenny Johnson, Abhinav R Cheedipudi, Ahmed D Mohammed, Ryan A W Ball, J Hunter Cox, Savannah K Pender, Amy Jolly, Kandy T Velázquez, Jay Potts and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Tori E PeacockDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Kenny JohnsonDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Abhinav R CheedipudiDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Ahmed D MohammedDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Ryan A W BallDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
J Hunter CoxDepartment of Pharmacology, Physiology, and Neuroscience, School of Medicine, University of South Carolina, Columbia, SC, United States.
Savannah K PenderDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Amy JollyDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Kandy T VelázquezDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Jay PottsDepartment of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC, United States.
Angela MurphyDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Norma FrizzellDepartment of Pharmacology, Physiology, and Neuroscience, School of Medicine, University of South Carolina, Columbia, SC, United States.
Colin EvansDepartment of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC, United States.
Jason L KubinakDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.

Funding

South Carolina IDeA Networks of Biomedical Research (SC INBRE V)P20GM103499 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI EDIE C GOLDSMITH · 2012 to 2026
$61.0M
B-cell-intrinsic MHCII Signaling is a Diversifying Force of Selection on IgA Repertoires and the Gut MicrobiotaR01AI155887 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI KUBINAK, JASON L · 2021 to 2025
$2.1M
Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial EncephalopathyR01NS126851 · NINDS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FRIZZELL, NORMA · 2022 to 2025
$1.5M
NIAID NIH HHS R01 AI155887NIGMS NIH HHS P20 GM103499NINDS NIH HHS R01 NS126851
6 · The paper itself

Abstract

Introduction: Acute polymicrobial sepsis is a life-threatening emergency caused by the body's immune response to bloodstream infection by two or more microbes. Early detection and management of sepsis have been the focus of global survey programs, driven by its association with hospital readmissions and long-term adverse health outcomes. Methods: Animal models are essential tools for studying mechanisms of sepsis pathogenesis and the only way to empirically dissect the acute phase of disease. With this in mind, the goal of the current study was two-fold: to demonstrate the feasibility of performing multiplexed longitudinal assessment of acute sepsis pathogenesis and to emphasize the granularity with which acute sepsis can be studied using this method. Using the fecal suspension test (FST) model of acute polymicrobial sepsis in C57BL/6 mice we simultaneously characterize hematological, immunological, and microbiological aspects of acute sepsis induction. Results: Our data shows that high dimensional flow cytometry paired with flow-based plasma cytokine measurements captures the dynamic shift from pro-inflammatory to anti-inflammatory immune responses during an acute septic event; highlighting the role of emergency myelopoiesis in this process. Additionally, myeloid cell heterogeneity is characterized and strongly implicates the emergence of myeloid derived suppressor like cells (MDSC-like cells) as central to this switch. Furthermore, we demonstrate a 16S-based method for studying the blood biome that allows for discrimination between endogenous (bacterial DNAemia) and exogenous (actively growing bacteria in blood) sources of microbial DNA. Using this approach, we demonstrate that polymicrobial sepsis in our model is due to outgrowth of Discussion: Collectively, the approach we describe simultaneously reduces research animal use, strengthens scientific rigor, provides a pre-clinical platform for biomarker discovery and the study of therapeutic interventions, and most importantly advances our ability to study the acute phase of sepsis that carries a high mortality rate and is difficult to prospectively study in humans.

Indexed as

CoinfectionSepsisAnimalsCytokinesDisease Models, AnimalFemaleFlow CytometryLongitudinal StudiesMaleMiceMice, Inbred C57BLMyeloid-Derived Suppressor CellsCytokinesblood biomeemergency myelopoiesissepsisseptic shockspectral flow cytometry

Identifiers

PMID41415274
PMCPMC12710661

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.